These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19952306)

  • 1. Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.
    Liu R; Liu Q; He S; Simpkins JW; Yang SH
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1006-12. PubMed ID: 19952306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats.
    Liu R; Wen Y; Perez E; Wang X; Day AL; Simpkins JW; Yang SH
    Brain Res; 2005 Oct; 1060(1-2):55-61. PubMed ID: 16212944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Morris DC; Zhang L; Zhang ZG; Lu M; Berens KL; Brown PM; Chopp M
    Stroke; 2001 Nov; 32(11):2635-40. PubMed ID: 11692028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
    Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
    Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke.
    Huang L; Wang J; Huang S; Siaw-Debrah F; Nyanzu M; Zhuge Q
    Biochem Biophys Res Commun; 2019 Aug; 516(2):565-570. PubMed ID: 31235258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
    Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke.
    Huang Y; Gu S; Han Z; Yang Z; Zhong L; Li L; Wang R; Yan F; Luo Y; Borlongan C; Lu J
    J Am Heart Assoc; 2023 Sep; 12(17):e029817. PubMed ID: 37655472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke.
    Peng T; Booher K; Moody MR; Yin X; Aronowski J; McPherson DD; Savitz SI; Kim H; Huang SL
    Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
    Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
    You YP
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.
    Ma Y; Li L; Niu Z; Song J; Lin Y; Zhang H; Du G
    Pharmacol Res; 2016 May; 107():291-299. PubMed ID: 27038532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
    Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
    Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke.
    Jia L; Chopp M; Zhang L; Lu M; Zhang Z
    Stroke; 2010 Sep; 41(9):2071-6. PubMed ID: 20671252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model.
    Fagan SC; Nagaraja TN; Fenstermacher JD; Zheng J; Johnson M; Knight RA
    Neurol Res; 2003 Jun; 25(4):377-82. PubMed ID: 12870264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
    Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
    J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
    J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.